CytoSurb

DGCI Approved Biocon's CytoSorb for COVID-19 Treatment

This is an extracorporeal blood purification (EBP) device which can help reduce pro-inflammatory cytokines levels in confirmed COVID-19 patients admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure.